Targeting Uncontrolled Erythrocytosis in Polycythemia Vera
Researchers demonstrated that treatment with rusfertide helped maintain safer hematocrit rates while reducing erythrocyte levels in patients with PV.
Researchers demonstrated that treatment with rusfertide helped maintain safer hematocrit rates while reducing erythrocyte levels in patients with PV.
Don’t miss out on an engaging Tweetorial by Florez Lab and Young Lung Cancer Initiative / cancer, Florez Lab, Lung cancer, OncoDaily, Oncology, tweetorial,
Show This Week in Cardiology, Ep Apr 26 2024 This Week in Cardiology – Apr 26, 2024
The number of measles cases around the world nearly doubled from 2022 to 2023, researchers say, presenting a challenge to efforts to achieve and maintain…
A Cleveland Clinic study presents new insights into the use of radiofrequency ablation for symptomatic thyroid nodules. months post-treatment.
An independent analysis of clinical trials of MDMA-assisted therapy raised doubts about the integrity of the studies. The sponsor is expecting the FDA to make…
Orthobiologics have become increasingly popular in recent years. OrthoInfo defines orthobiologics as “therapies developed from biologic (natural) substances that can be used by orthopaedic specialists…
Exclusive: New research shows extent to which schools are struggling to provide qualified teachers for every class
Background:. Venous thromboembolism (VTE) is a common complication among patients with cancer. Patients with cancer and VTE are at a markedly increased ris
Objective To determine whether the combined use of glucagon-like peptide-1 (GLP-1) receptor agonists and sodium-glucose cotransporter-2 (SGLT-2) inhibitors is associated with a decreased risk of…
The Global Burden of Disease assessment estimates that 20% of global type 2 diabetes cases are related to chronic exposure to particulate matter (PM) with…